ClinicalThought

Share

Program Content

Activities

  • Targeting TIGIT: Commentary
    Targeting TIGIT: A Novel Mechanism to Inhibit the Immune Checkpoint Pathway
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 14, 2022

    Expires: April 13, 2023

  • Anti-TIGIT Therapy
    Anti-TIGIT Therapy: Current Evidence and Key Ongoing Trials
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 03, 2022

    Expires: May 02, 2023

Faculty

cover img faculity

Ani Balmanoukian, MD

Director of Thoracic Oncology
Medical Oncology
The Angeles Clinic and Research Institute, a Cedars-Sinai Affiliate
Los Angeles, California

cover img faculity

Diwakar Davar, MD

Assistant Professor
Melanoma and Phase I Therapeutics
Division of Hematology/Oncology
Department of Medicine
University of Pittsburgh Hillman Cancer Center
Pittsburgh, Pennsylvania

cover img faculity

Jyoti D. Patel, MD

Professor of Medicine
Division of Hematology and Oncology
Medical Director for Thoracic Oncology
Assistant Director for Clinical Research
Associate Vice Chair of Clinical Research
Department of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Genentech, a member of the Roche Group